Pharmaceutical Business review

Biolase names new CEO

Mr Mulder replaces Jake Philip, who has resigned his positions as CEO and director of the company to pursue other interests.

Previously, Mr Mulder served for two years as the CFO and COO of American LaFrance, a private equity turn-around company. From 2002 through 2005, Mr Mulder served as the executive vice president, chief administrative officer, and senior financial officer of Salton, a distributor of household appliances.

Mr Mulder began his professional career in accounting and consulting with Arthur Anderson, and holds an MBA from Duke University, Fuqua School of Business.

George d’Arbeloff, chairman of the board of Biolase, said: “We are fortunate to have someone with Dave’s extensive domestic and international financial and operational background to take over the role of CEO at this pivotal time in the company’s history. He will be able to hit the ground running as he has been a key part of the Biolase senior management team working closely with the board and the entire organization since joining the company in April 2008.”